In hereditary spastic paraplegia, a neurodegenerative disease characterized by a motor neuron phenotype is thought that NIPA1/SPG6 inhibits BMP signaling by binding to the type II BMP receptor (BMPR2) and promoting its endocytic internalization and degradation [111]. This evidence concerns the gene BMPR2 and neurodegenerative disease.